NCT00672399 - Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

exenatide

Subcutaneously injected, 10 mcg, single doses

DRUG

Moxifloxacin

oral, 400 mg tablet, single doses

DRUG

Placebo

Subcutaneously injucted in an amount equivalent to exenatide; or orally as a tablet identical in appearance to Moxifloxacin. Both are single doses

Trial Locations (2)

Reseach Site, Derriford

Research Site, Leeds